Discussion
The use of certain antidopaminergic medications (ADMs), or those that block the activity of a brain signaling molecule called dopamine, may be linked to a faster progression of Huntington’s disease, according to a new analysis of clinical trial data. “Our study is not intended to inform changes to the…